Literature DB >> 28503964

Recent advances in intensity modulated radiotherapy and proton therapy for esophageal cancer.

Mian Xi1, Steven H Lin2.   

Abstract

INTRODUCTION: Radiotherapy is an important component of the standard of care for esophageal cancer. In the past decades, significant improvements in the planning and delivery of radiation techniques have led to better dose conformity to the target volume and improved normal tissue sparing. Areas covered: This review focuses on the advances in radiotherapy techniques and summarizes the availably dosimetric and clinical outcomes of intensity-modulated radiation therapy (IMRT), volumetric modulated arc therapy, proton therapy, and four-dimensional radiotherapy for esophageal cancer, and discusses the challenges and future development of proton therapy. Expert commentary: Although three-dimensional conformal radiotherapy is the standard radiotherapy technique in esophageal cancer, the retrospectively comparative studies strongly suggest that the dosimetric advantage of IMRT over three-dimensional conformal radiotherapy can translate into improved clinical outcomes, despite the lack of prospective randomized evidence. As a novel form of conventional IMRT technique, volumetric modulated arc therapy can produce equivalent or superior dosimetric quality with significantly higher treatment efficiency in esophageal cancer. Compared with photon therapy, proton therapy has the potential to achieve further clinical improvement due to their physical properties; however, prospective clinical data, long-term results, and cost-effectiveness are needed.

Entities:  

Keywords:  Esophageal cancer; dosimetry; intensity-modulated radiation therapy; proton beam therapy; survival; toxicity; volumetric modulated arc therapy

Mesh:

Year:  2017        PMID: 28503964     DOI: 10.1080/14737140.2017.1331130

Source DB:  PubMed          Journal:  Expert Rev Anticancer Ther        ISSN: 1473-7140            Impact factor:   4.512


  13 in total

1.  Radiobiological Comparison of Acuros External Beam and Anisotropic Analytical Algorithm on Esophageal Carcinoma Radiotherapy Treatment Plans.

Authors:  Lin Wang; Jianping Zhang; Miaoyun Huang; Benhua Xu; Xiaobo Li
Journal:  Dose Response       Date:  2022-07-08       Impact factor: 2.623

2.  Primary impact of Gli1 on radioresistance in esophageal cancer.

Authors:  Fei Yao; Jinjing Yu; Yulin He; Jiaqi Liu; Huan Li; Qun Liu; Hui Long; Qingming Wu
Journal:  Oncol Lett       Date:  2019-09-10       Impact factor: 2.967

3.  Dynamic changes in T-cell subsets and C-reactive protein after radiation therapy in lung cancer patients and correlation with symptomatic radiation pneumonitis treated with steroid therapy.

Authors:  Lu Bai; Bao-Sen Zhou; Yu-Xia Zhao
Journal:  Cancer Manag Res       Date:  2019-08-22       Impact factor: 3.989

4.  A technique to reduce skin toxicity in radiotherapy treatment planning for esophageal cancer.

Authors:  Wanfu Yang; Zhihua Yang; Ting Zhao; Wei Ding; Wei Kong; Pan Wang; Hongqiang Ye; Zixin Zhang; Jun Shang
Journal:  J Appl Clin Med Phys       Date:  2020-01-11       Impact factor: 2.102

5.  Comparing efficacy of high-dose rate brachytherapy versus helical tomotherapy in the treatment of cervical cancer.

Authors:  Seongmin Kim; Sanghoon Lee; Jin Hwa Hong; Young Je Park; Jae Yun Song; Jae Kwan Lee; Nak Woo Lee
Journal:  J Gynecol Oncol       Date:  2019-12-20       Impact factor: 4.401

6.  Evofosfamide sensitizes esophageal carcinomas to radiation without increasing normal tissue toxicity.

Authors:  Linda Spiegelberg; Stefan J van Hoof; Rianne Biemans; Natasja G Lieuwes; Damiënne Marcus; Raymon Niemans; Jan Theys; Ala Yaromina; Philippe Lambin; Frank Verhaegen; Ludwig J Dubois
Journal:  Radiother Oncol       Date:  2019-08-17       Impact factor: 6.280

7.  Fixed-jaw technique to improve IMRT plan quality for the treatment of cervical and upper thoracic esophageal cancer.

Authors:  Wei Song; Hong Lu; Jie Liu; Di Zhao; Jun Ma; Biyun Zhang; Dahai Yu; Xinchen Sun; Jinkai Li
Journal:  J Appl Clin Med Phys       Date:  2019-08-28       Impact factor: 2.102

8.  Hypoxic tumour cell-derived exosomal miR-340-5p promotes radioresistance of oesophageal squamous cell carcinoma via KLF10.

Authors:  Fangyu Chen; Bing Xu; Jie Li; Xi Yang; Junjie Gu; Xijuan Yao; Xinchen Sun
Journal:  J Exp Clin Cancer Res       Date:  2021-01-23

9.  Factors relevant to the prognosis of patients with esophageal cancer who received intensity-modulated radiotherapy.

Authors:  Hongmei Yin; Duojie Li; Chaomang Zhu; Mingxi Wang; Nannan Wei
Journal:  Thorac Cancer       Date:  2018-08-01       Impact factor: 3.500

10.  Competing risk nomogram to predict cancer-specific survival in esophageal cancer during the intensity-modulated radiation therapy era: A single institute analysis.

Authors:  Shengguang Zhao; Weixiang Qi; Jiayi Chen
Journal:  Oncol Lett       Date:  2020-03-06       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.